Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Trisomy 8 in primary esthesioneuroblastoma.

D R VanDevanter1, D George, M A McNutt

  • 1Clinical Research Division, Swedish Hospital Medical Center, Seattle, WA 98104.

Cancer Genetics and Cytogenetics
|November 1, 1991
PubMed
Summary

Trisomy 8, an extra copy of chromosome 8, is a common finding in esthesioneuroblastoma and other small round cell tumors. This cytogenetic anomaly may offer a selective advantage for tumor development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cisplatin-gemcitabine-durvalumab reintroduction in advanced biliary tract cancer: a multinational real-world analysis.

ESMO open·2026
Same author

Baseline neutrophil-to-eosinophil ratio and neutrophil-to-lymphocyte ratio as prognostic markers in patients with unresectable biliary tract cancer treated with gemcitabine-cisplatin-durvalumab: an international, multicentre, retrospective cohort study.

ESMO gastrointestinal oncology·2026
Same author

ESMO podcast on upper GI cancers: highlights in hepatocellular carcinoma and pancreatic cancer from ESMO 2025.

ESMO gastrointestinal oncology·2026
Same author

Editorial: Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Prior to Liver Transplantation-Current Evidence and Future Directions. Authors' reply.

Alimentary pharmacology & therapeutics·2026
Same author

ESMO adaptation of Lines of Systemic Therapy (EnLiST): a consensus framework for standardising the designation of lines of therapy in solid tumours.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

Quantitative benefit-risk assessment of data from the phase III ClarIDHy study of ivosidenib versus placebo in patients with m<i>IDH1</i> cholangiocarcinoma.

ESMO gastrointestinal oncology·2026

Area of Science:

  • Oncology
  • Cytogenetics
  • Molecular Biology

Background:

  • Esthesioneuroblastoma is a rare cancer originating from olfactory epithelium neuroectodermal stem cells.
  • Understanding the genetic basis of esthesioneuroblastoma is crucial for diagnosis and treatment.

Observation:

  • A primary esthesioneuroblastoma exhibited trisomy 8 as its sole cytogenetic abnormality after in vitro culture.
  • Previous studies reported trisomy 8 and the t(11;22) translocation in metastatic esthesioneuroblastoma cell lines.

Findings:

  • An extra copy of chromosome 8 (trisomy 8) is frequently observed in undifferentiated small round cell tumors.
  • This includes esthesioneuroblastoma, Ewing's sarcoma, and rhabdomyosarcoma, often co-occurring with the t(11;22) translocation.

Related Experiment Videos

Implications:

  • Trisomy 8 appears to be a common phenomenon in specific pediatric and adult malignancies.
  • The presence of trisomy 8 may confer a selective growth advantage to these tumor types.